0001752724-23-214314.txt : 20230925 0001752724-23-214314.hdr.sgml : 20230925 20230925170042 ACCESSION NUMBER: 0001752724-23-214314 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230731 FILED AS OF DATE: 20230925 DATE AS OF CHANGE: 20230925 PERIOD START: 20231031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BNY Mellon ETF Trust CENTRAL INDEX KEY: 0001493580 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-23477 FILM NUMBER: 231276431 BUSINESS ADDRESS: STREET 1: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10286 BUSINESS PHONE: 212-922-6400 MAIL ADDRESS: STREET 1: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10286 FORMER COMPANY: FORMER CONFORMED NAME: Dreyfus ETF Trust DATE OF NAME CHANGE: 20100607 0001493580 S000073736 BNY Mellon Concentrated International ETF C000230859 BNY Mellon Concentrated International ETF BKCI NPORT-P 1 primary_doc.xml NPORT-P false 0001493580 XXXXXXXX S000073736 C000230859 BNY Mellon ETF Trust 811-23477 0001493580 549300E2C8EQYJ7B0H81 240 Greenwich Street New York 10286 212-922-6400 BNY Mellon Concentrated International ETF S000073736 549300X9FYRRBEHODG85 2023-10-31 2023-07-31 N 76847264.65 50474.53 76796790.12 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 27103.65000000 N Merck KGaA 529900OAREIS0MOPTW25 Merck KGaA 000000000 11360.00000000 NS 1995962.62000000 2.599018288239 Long EC CORP DE N 1 N N N Experian PLC 635400RXXHHYT1JTSZ26 Experian PLC 000000000 62024.00000000 NS 2395120.90000000 3.118777355482 Long EC CORP IE N 1 N N N Dreyfus Institutional Preferred Government Money Market Fund 549300RBWL04JG8SIX57 Dreyfus Institutional Preferred Government Money Market Fund 000000000 1419793.32000000 NS USD 1419793.32000000 1.848766488523 Long STIV RF US N 1 N N N Compass Group PLC 2138008M6MH9OZ6U2T68 Compass Group PLC 000000000 140826.00000000 NS 3663380.89000000 4.770226573631 Long EC CORP GB N 1 N N N L'Oreal SA 529900JI1GG6F7RKVI53 L'Oreal SA 000000000 6240.00000000 NS 2903538.21000000 3.780806730936 Long EC CORP FR N 1 N N N LVMH Moet Hennessy Louis Vuitt IOG4E947OATN0KJYSD45 LVMH Moet Hennessy Louis Vuitton SE 000000000 3616.00000000 NS 3371885.21000000 4.390659042820 Long EC CORP FR N 1 N N N Novo Nordisk A/S 549300DAQ1CVT6CXN342 Novo Nordisk A/S 000000000 20698.00000000 NS 3335549.86000000 4.343345411687 Long EC CORP DK N 1 N N N ASML Holding NV 724500Y6DUVHQD6OXN27 ASML Holding NV 000000000 3520.00000000 NS 2524182.52000000 3.286833363810 Long EC CORP NL N 1 N N N adidas AG 549300JSX0Z4CW0V5023 adidas AG 000000000 9600.00000000 NS 1942166.03000000 2.528967717225 Long EC CORP DE N 1 N N N Nestle SA KY37LUS27QQX7BB93L28 Nestle SA 000000000 21760.00000000 NS 2666944.33000000 3.472728906810 Long EC CORP CH N 1 N N N Daikin Industries Ltd 549300Y7FWSTSHMW5Y57 Daikin Industries Ltd 000000000 12800.00000000 NS 2581323.59000000 3.361238908509 Long EC CORP JP N 1 N N N Air Liquide SA 969500MMPQVHK671GT54 Air Liquide SA 000000000 18656.00000000 NS 3350900.67000000 4.363334280982 Long EC CORP FR N 1 N N N CLP Holdings Ltd 25490002BUTSMP94GO68 CLP Holdings Ltd 000000000 288054.00000000 NS 2343539.00000000 3.051610615935 Long EC CORP HK N 1 N N N Prudential PLC 5493001Z3ZE83NGK8Y12 Prudential PLC 000000000 164444.00000000 NS 2284501.35000000 2.974735462810 Long EC CORP HK N 1 N N N TotalEnergies SE 529900S21EQ1BO4ESM68 TotalEnergies SE 000000000 47901.00000000 NS 2910400.51000000 3.789742390863 Long EC CORP FR N 1 N N N SAP SE 529900D6BF99LW9R2E68 SAP SE 000000000 21760.00000000 NS 2976299.07000000 3.875551393944 Long EC CORP DE N 1 N N N CapitaLand Ascendas REIT 549300ILIBAEMQZK3L20 CapitaLand Ascendas REIT 000000000 1280000.00000000 NS 2704869.34000000 3.522112494250 Long EC CORP SG N 1 N N N Coloplast A/S 529900NN7SOJ5QG82X67 Coloplast A/S 000000000 17120.00000000 NS 2127938.15000000 2.770868608798 Long EC CORP DK N 1 N N N Shin-Etsu Chemical Co Ltd 353800PX8Q64N86H5W41 Shin-Etsu Chemical Co Ltd 000000000 80000.00000000 NS 2631146.10000000 3.426114679908 Long EC CORP JP N 1 N N N CSL Ltd 529900ECSECK5ZDQTE14 CSL Ltd 000000000 12640.00000000 NS 2279811.92000000 2.968629178950 Long EC CORP AU N 1 N N N TSMC 549300KB6NK5SBD14S87 Taiwan Semiconductor Manufacturing Co Ltd 874039100 24000.00000000 NS USD 2379600.00000000 3.098567005576 Long EC CORP TW N 1 N N N SGS SA 2138007JNS19JHNA2336 SGS SA 000000000 23200.00000000 NS 2246440.00000000 2.925174341909 Long EC CORP CH N 1 N N N Keyence Corp 529900M7PQBS7A89DZ11 Keyence Corp 000000000 6400.00000000 NS 2868337.26000000 3.734970244873 Long EC CORP JP N 1 N N N AIA Group Ltd ZP5ILWVSYE4LJGMMVD57 AIA Group Ltd 000000000 264028.00000000 NS 2620339.69000000 3.412043245434 Long EC CORP HK N 1 N N N SMC Corp 353800O40V08DOZ70X62 SMC Corp 000000000 3200.00000000 NS 1667873.33000000 2.171800836198 Long EC CORP JP N 1 N N N Kone Oyj 2138001CNF45JP5XZK38 Kone Oyj 000000000 40799.00000000 NS 2092210.40000000 2.724346156565 Long EC CORP FI N 1 N N N Roche Holding AG 549300U41AUUVOAAOB37 Roche Holding AG 000000000 7136.00000000 NS 2214324.41000000 2.883355419594 Long EC CORP CH N 1 N N N Alimentation Couche-Tard Inc 549300OSW32RVX8CCZ87 Alimentation Couche-Tard Inc 01626P148 76001.00000000 NS 3847743.34000000 5.010291880673 Long EC CORP CA N 1 N N N Hoya Corp 353800X4VR3BHEUCJB42 Hoya Corp 000000000 19200.00000000 NS 2230878.99000000 2.904911763257 Long EC CORP JP N 1 N N N Amadeus IT Group SA 9598004A3FTY3TEHHN09 Amadeus IT Group SA 000000000 29419.00000000 NS 2109628.57000000 2.747027013373 Long EC CORP ES N 1 N N N 2023-09-19 BNY Mellon ETF Trust James Windels James Windels Treasurer XXXX NPORT-EX 2 951981BNYM093023.htm
STATEMENT
OF
INVESTMENTS
July
31,
2023
(Unaudited)
1
Description
Shares
Value
($)
Common
Stocks
98.1%
Australia
3.0%
CSL
Ltd.
12,640
2,279,812
Canada
5.0%
Alimentation
Couche-Tard,
Inc.
76,001
3,847,743
Denmark
7.1%
Coloplast
A/S,
Class
B
17,120
2,127,938
Novo
Nordisk
A/S,
Class
B
20,698
3,335,550
5,463,488
Finland
2.7%
Kone
OYJ,
Class
B
40,799
2,092,210
France
16.3%
Air
Liquide
SA
18,656
3,350,901
L'Oreal
SA
6,240
2,903,538
LVMH
Moet
Hennessy
Louis
Vuitton
SE
3,616
3,371,885
TotalEnergies
SE
47,901
2,910,401
12,536,725
Germany
9.0%
adidas
AG
9,600
1,942,166
Merck
KGaA
11,360
1,995,963
SAP
SE
21,760
2,976,299
6,914,428
Hong
Kong
9.5%
AIA
Group
Ltd.
264,028
2,620,340
CLP
Holdings
Ltd.
288,054
2,343,539
Prudential
PLC
164,444
2,284,501
7,248,380
Ireland
3.1%
Experian
PLC
62,024
2,395,121
Japan
15.6%
Daikin
Industries
Ltd.
12,800
2,581,324
Hoya
Corp.
19,200
2,230,879
Keyence
Corp.
6,400
2,868,337
Shin-Etsu
Chemical
Co.
Ltd.
80,000
2,631,146
SMC
Corp.
3,200
1,667,873
11,979,559
Netherlands
3.3%
ASML
Holding
NV
3,520
2,524,183
Singapore
3.5%
CapitaLand
Ascendas
REIT
(a)
1,280,000
2,704,869
STATEMENT
OF
INVESTMENTS
(continued)
2
See
Notes
to
Statement
of
Investments
Description
Shares
Value
($)
Common
Stocks
98.1%
(continued)
Spain
2.8%
Amadeus
IT
Group
SA
29,419
2,109,629
Switzerland
9.3%
Nestle
SA
21,760
2,666,944
Roche
Holding
AG
7,136
2,214,325
SGS
SA
23,200
2,246,440
7,127,709
Taiwan
3.1%
Taiwan
Semiconductor
Manufacturing
Co.
Ltd.,
ADR
24,000
2,379,600
United
Kingdom
4.8%
Compass
Group
PLC
140,826
3,663,381
Total
Common
Stocks
(cost
$68,935,436)
75,266,837
Investment
Companies
1.8%
Registered
Investment
Companies
1.8%
Dreyfus
Institutional
Preferred
Government
Money
Market
Fund,
Institutional
Shares,
5.30%
(b)(c)
(cost
$1,419,793)
1,419,793
1,419,793
Total
Investments
(cost
$70,355,229)
99.9%
76,686,630
Cash
and
Receivables
(Net)
0.1%
110,160
Net
Assets
100.0%
76,796,790
ADR—American
Depositary
Receipt
REIT—Real
Estate
Investment
Trust
(a)
Investment
in
a
real
estate
investment
trust.
(b)
Investment
in
affiliated
issuer.
The
investment
objective
of
this
investment
company
is
publicly
available
and
can
be
found
within
the
investment
company’s
prospectus.
(c)
The
rate
shown
is
the
1-day
yield
as
of
July
31,
2023.
NOTES
TO
STATEMENT
OF
INVESTMENTS
(Unaudited)
3
The
Financial
Accounting
Standards
Board
(“FASB”)
Accounting
Standards
Codification
(“ASC”)
is
the
exclusive
reference
of
authoritative
U.S.
generally
accepted
accounting
principles
(“GAAP”)
recognized
by
the
FASB
to
be
applied
by
nongovernmental
entities.
Rules
and
interpretive
releases
of
the
Securities
and
Exchange
Commission
(“SEC”)
under
authority
of
federal
laws
are
also
sources
of
authoritative
GAAP
for
SEC
registrants. BNY
Mellon
Concentrated
International
ETF (the
“fund”)
is an
investment
company
and
applies
the
accounting
and
reporting
guidance
of
the
FASB
ASC
Topic
946
Financial
Services-Investment
Companies. The
fund’s
financial
statements
are
prepared
in
accordance
with
GAAP,
which
may
require
the
use
of
management
estimates
and
assumptions.
Actual
results
could
differ
from
those
estimates.  
(a)
Portfolio
valuation:
The
fair
value
of
a
financial
instrument
is
the
amount
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date
(i.e.,
the
exit
price).
GAAP
establishes
a
fair
value
hierarchy
that
prioritizes
the
inputs
of
valuation
techniques
used
to
measure
fair
value.
This
hierarchy
gives
the
highest
priority
to
unadjusted
quoted
prices
in
active
markets
for
identical
assets
or
liabilities
(Level
1
measurements)
and
the
lowest
priority
to
unobservable
inputs
(Level
3
measurements).
Additionally,
GAAP
provides
guidance
on
determining
whether
the
volume
and
activity
in
a
market
has
decreased
significantly
and
whether
such
a
decrease
in
activity
results
in
transactions
that
are
not
orderly.
GAAP
requires
enhanced
disclosures
around
valuation
inputs
and
techniques
used
during
annual
and
interim
periods.
Various
inputs
are
used
in
determining
the
value
of
the
fund’s
investments
relating
to
fair
value
measurements.
These
inputs
are
summarized
in
the
three
broad
levels
listed
below:
Level
1
unadjusted
quoted
prices
in
active
markets
for
identical
investments.
Level
2
other
significant
observable
inputs
(including
quoted
prices
for
similar 
investments,
interest
rates,
prepayment
speeds,
credit
risk,
etc.).
Level
3
significant
unobservable
inputs
(including
the
fund’s
own
assumptions
in
determining
the
fair
value
of
investments).
The
inputs
or
methodology
used
for
valuing
securities
are
not
necessarily
an
indication
of
the
risk
associated
with
investing
in
those
securities.
Changes
in
valuation
techniques
may
result
in
transfers
in
or
out
of
an
assigned
level
within
the
disclosure
hierarchy.
Valuation
techniques
used
to
value
the
fund’s
investments
are
as
follows:
NOTES
TO
STATEMENT
OF
INVESTMENTS
(Unaudited)
(continued)
4
BNY
Mellon
ETF
Trust’s
(the
“Trust”) Board
of
Trustees
(the
“Board”)
has
designated
the
Adviser
as
the
fund’s
valuation
designee
to
make
all
fair
value
determinations
with
respect
to
the
fund’s
portfolio
of
investments,
subject
to
the
Board’s
oversight
and
pursuant
to
Rule
2a-5
under
the
Act.
Investments
in
equity
securities,
including
ETFs
(but
not
including
investments
in
other
open-end
registered
investment
companies)
generally
are
valued
at
the
last
sales
price
on
the
day
of
valuation
on
the
securities
exchange
or
national
securities
market
on
which
such
securities
primarily
are
traded.
Securities
listed
on
the
National
Association
of
Securities
Dealers
Automated
Quotation
System
(“NASDAQ”)
for
which
market
quotations
are
available
will
be
valued
at
the
official
closing
price.
If
there
are
no
transactions
in
a
security,
or
no
official
closing
prices
for
a
NASDAQ
market-listed
security
on
that
day,
the
security
will
be
valued
at
the
average
of
the
most
recent
bid
and
asked
prices.
Bid
price
is
used
when
no
asked
price
is
available.
Open
short
positions
for
which
there
is
no
sale
price
on
a
given
day
are
valued
at
the
lowest
asked
price.
Registered
investment
companies
that
are
not
traded
on
an
exchange
are
valued
at
their
net
asset
value.
All
of
the
preceding
securities
are
generally
categorized
within
Level
1
of
the
fair
value
hierarchy. 
When
market
quotations
or
official
closing
prices
are
not
readily
available,
or
are
determined
not
to
reflect
fair
value
accurately,
they are
valued
at
fair
value
as
determined
in
good
faith
based
on
procedures
approved
by
the
Board.
Fair
value
of
investments
may
be
determined
by
valuation
designee
using
such
information
as
it
deems
appropriate
under
the
circumstances.
Certain
factors
may
be
considered
when
fair
valuing
investments
such
as:
fundamental
analytical
data,
the
nature
and
duration
of
restrictions
on
disposition,
an
evaluation
of
the
forces
that
influence
the
market
in
which
the
securities
are
purchased
and
sold,
and
public
trading
in
similar
securities
of
the
issuer
or
comparable
issuers.
These
securities
are
either
categorized
within
Level
2
or
3
of
the
fair
value
hierarchy
depending
on
the
relevant
inputs
used.
For
securities
where
observable
inputs
are
limited,
assumptions
about
market
activity
and
risk
are
used
and
are
generally
categorized
within
Level
3
of
the
fair
value
hierarchy.
Investments
denominated
in
foreign
currencies
are
translated
to
U.S.
dollars
at
the
prevailing
rates
of
exchange.
The
table
below
summarizes
the
inputs
used
as
of July
31,
2023
in
valuing
the
fund’s
investments:
5
Fair
Value
Measurements
Additional
investment
related
disclosures
are
hereby
incorporated
by
reference
to
the
annual
and
semi-annual
reports
previously
filed
with
the
SEC
on
Form
N-CSR.
At July
31,
2023,
accumulated
net
unrealized
appreciation on
investments
was
$6,331,401,
consisting
of
gross
appreciation
of
$7,652,115
and
gross
depreciation
of
$1,320,714.
At
July
31,
2023,
the
cost
of
investments
for
federal
income
tax
purposes
was
substantially
the
same
as
the
cost
for
financial
reporting
purposes
(see
the
Statement
of
Investments).
Level
1
-
Unadjusted
Quoted
Prices
Level
2
-
Other
Significant
Observable
Inputs
Level
3
-
Significant
Unobservable
Inputs
Total
Assets
($)
Investments
In
Securities:
Common
Stocks
75,266,837
75,266,837
Investment
Companies
1,419,793
1,419,793
See
Statement
of
Investments
for
additional
detailed
categorizations,
if
any.